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Background: Streptococcus agalactiae is a major cause of bovine mastitis, which is the dominant health disorder
affecting milk production within the dairy industry and is responsible for substantial financial losses to the industry
worldwide. However, there is considerable evidence for host adaptation (ecotypes) within S. agalactiae, with both
bovine and human sourced isolates showing a high degree of distinctiveness, suggesting differing ability to cause
mastitis. Here, we (i) generate RNAseq data from three S. agalactiae isolates (two putative bovine adapted and one
human) and (ii) compare publicly available whole genome shotgun sequence data from an additional 202 isolates,
obtained from six host species, to elucidate possible genetic factors/adaptations likely important for S. agalactiae
growth and survival in the bovine mammary gland.
Results: Tests for differential expression showed distinct expression profiles for the three isolates when grown in
bovine milk. A key finding for the two putatively bovine adapted isolates was the up regulation of a lactose
metabolism operon (Lac.2) that was strongly correlated with the bovine environment (all 36 bovine sourced isolates
on GenBank possessed the operon, in contrast to only 8/151 human sourced isolates). Multi locus sequence typing
of all genome sequences and phylogenetic analysis using conserved operon genes from 44 S. agalactiae isolates
and 16 additional Streptococcus species provided strong evidence for acquisition of the operon via multiple lateral
gene transfer events, with all Streptococcus species known to be major causes of mastitis, identified as possible
donors. Furthermore, lactose fermentation tests were only positive for isolates possessing Lac.2. Combined, these
findings suggest that lactose metabolism is likely an important adaptation to the bovine environment. Additional
up regulation in the bovine adapted isolates included genes involved in copper homeostasis, metabolism of purine,
pyrimidine, glycerol and glucose, and possibly aminoglycoside antibiotic resistance.
Conclusion: We detected several genetic factors likely important in S. agalactiae’s adaptation to the bovine
environment, in particular lactose metabolism. Of concern is the up regulation of a putative antibiotic resistance
gene (GCN5-related N-acetyltransferase) that might reflect an adaptation to the use of aminoglycoside antibiotics
within this environment.
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In addition to causing severe invasive infections in adults
and neonates (e.g. pneumonia, meningitis, and septi-
cemia) [1-3], Streptococcus agalactiae (Group B Strepto-
coccus; GBS) is a major cause of bovine mastitis [4,5],
which is the dominant health disorder affecting milk
production in the dairy industry, and is responsible for
significant financial losses worldwide [6-11]. S. agalactiae
has been isolated from a diversity of vertebrate hosts ran-
ging from humans to crocodiles and fish [12-14], and
there is considerable evidence for host adaptation
among strains, with both human and bovine sourced
isolates showing a high degree of genetic distinctive-
ness [15-20]. Therefore, the objectives of this study
were to (i) assess how the genomic gene expression of
bovine sourced S. agalactiae (putative bovine adapted)
responded to growth in bovine milk when compared to
human sourced S. agalactiae, and (ii) place our findings
into a wider context via comparison of over 200 add-
itional S. agalactiae genome sequences obtained from a
variety of host species.
A principle now generally regarded as common to
most or all bacteria is that of the pan-genome, which is
comprised of both a set of core and dispensable genes,
with only the former present in all isolates of that spe-
cies [21]. There is now abundant evidence to support
the view that the dispensable genes are fundamental to
adaptive and phenotypic differences between strains
[20,22-28]. Earlier genomic studies of S. agalactiae gene
expression used microarrays and did not focus on poten-
tial ecotypic adaptation. [29-33]. Here we present the
first comparative transcriptomic study of S. agalactiae
based on RNAseq data. The comparison involves three
S. agalactiae strains representing distinct ecotypes to
elucidate possible genetic factors/adaptations likely im-
portant for S. agalactiae growth and survival in the bo-
vine mammary gland. Our findings reveal several genetic
factors likely important in S. agalactiae’s adaptation to




The putative bovine adapted S. agalactiae strain used in
this study (FSL S3-586) was obtained from a quarter
milk sample isolated from a cow with mastitis in
Wayne County, NY, USA [18]. The strain was isolated
in 2001 and is MLST sequence type (ST) 67. ST-67 has
been frequently isolated from cows suffering with mas-
titis [15]. The human sourced strain (CCUG 37738)
was isolated from the blood of a female newborn with
sepsis in Göteborg, Sweden (1994). The strain was de-
termined here to be ST-19 using its genome sequence
(GenBank accession number: ALQP01000000). ST-19has been frequently isolated from human sources
[15,34-36]. S. agalactiae strains from the ST-23 lineage
have possibly the widest host range. Strains have been
isolated from humans, cattle, dogs, crocodiles, and grey
seals, with the ST showing high frequency in both hu-
man and bovine environments [5,12,13,15,34-36]. Given
that strains from this lineage might be adapted to both
human and bovine environments, we also included a
strain with this ST in our analysis. We selected strain
NEM316, as this strain has been included in numerous
previous studies (including whole-genome transcrip-
tome analysis) and its genome has been sequenced
[12,15,29,32,35,37-39]. While the strain has been de-
scribed in the literature as being a human isolate,
Sørensen et al. [35] showed its isolation source to be
unknown.
No experimental research on vertebrates or any regu-
lated invertebrates was performed. Compliance with the
ARRIVE (Animal Research: Reporting In Vivo Experi-
ments) guidelines is not applicable.Bacteria culturing
All strains were grown, in triplicate, in untreated bovine
milk and Todd Hewitt Broth with 0.5% yeast extract
(THY) at 37ºC and normal atmospheric conditions. Bovine
milk with low somatic cell count (< 200,000 cells/mL) was
collected and pooled from four cows (seven quarters total),
approximately 30 minutes prior to inoculation. Overnight
cultures of the strains were used to inoculate the milk and
THY media to 1:100 dilution (500 μL overnight culture in
50 mL media). Cultures were grown to mid-exponential
phase and harvested.
Growth curve measurements for each strain were ob-
tained using the drop plate method [40]. For each one-
hour time point, serial dilutions were made (in PBS
pH 7.4) and plated (five drops of 10 μL in duplicate for
each of four to six dilutions) on TSAII with 0.5% sheep
blood and incubated overnight. After 24 hours, colonies
were counted and CFU/μL was calculated. Drops were
considered countable if they contained 3-30 colonies.
Standard error for each pair of replicates at each time
point was calculated (for some time points, only one drop
was countable, precluding standard error calculation).Lactose fermentation
Strains were grown at 37°C in 7 mL Phenol Red Broth
Base with Meat Extract (HiMedia) supplemented with
1% lactose (BD Difco). After 7 days the color of the
media was noted. The media changed color to either yel-
low or orange. Two pH measurements were taken for
each. For yellow the average pH was 4.6, for orange the
average pH was 6.5. A color change to yellow was taken
as an indication of lactose fermentation.







NEM316 Milk 1 29,089,124 27,350,545
NEM316 Milk 2 40,554,665 38,161,713
NEM316 Milk 3 35,497,113 33,357,550
NEM316 Broth 1 23,013,312 21,250,407
NEM316 Broth 2 23,145,072 21,484,496
CCUG
37738
Milk 1 20,106,316 7,516,242
CCUG
37738
Milk 2 16,800,749 6,494,892
CCUG
37738
Milk 3 28,308,724 11,028,696
CCUG
37738
Broth 1 44,274,054 19,357,826
CCUG
37738
Broth 2 27,893,761 11,196,100
CCUG
37738
Broth 3 17,763,818 7,925,653
FSL S3-586 Milk 1 29,138,705 8,033,022
FSL S3-586 Milk 2 27,373,266 4,909,064
FSL S3-586 Milk 3 16,688,288 6,786,044
FSL S3-586 Broth 1 15,172,203 4,505,824
FSL S3-586 Broth 2 21,093,103 6,750,884
The average proportion of reads passing the Illumina quality filter for each
replicate was 94.6% (range = 93-97%). The number of aligned reads excludes
reads ambiguously aligned to multiple locations within the respective
genome sequence.
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and sequencing
Milk cultures at mid-exponential phase were centri-
fuged at 3,500 rpm and 4ºC for 30 minutes to pellet the
bacteria. Whey and fat were removed and the pellet re-
suspended in 9.0 mL of 1:2 mix of phosphate buffered
saline (PBS) and RNAprotect (Qiagen). The solution
was filtered through a five-micron filter to remove in-
tact bovine cells while leaving behind S. agalactiae cells
(size ≤ 1 micron). Cells were centrifuged at 5000 rpm
for 10 minutes, supernatant removed, and the pellet
frozen at -80ºC. THY cultures at mid-exponential phase
were centrifuged at 3,500 rpm and 4ºC for 30 minutes
to pellet the bacteria. The pellet was re-suspended in
1.0 mL RNAprotect. Following a second centrifugation
at 5,000 rpm for 10 minutes, the supernatant was re-
moved and the pellet frozen at -80ºC. All pellets were
re-suspended in 280 μL of TE and combined with
300 μL of acidic phenol:choloroform (Ambion) and 250 μL
of 0.1 mm glass beads (BioSpec Products). Cells were
mechanically disrupted and centrifuged at 13,200 rpm for
10 minutes to separate them. 200 μL of the supernatant
was combined with 700 μL Qiagen RLT buffer containing
7 μL β-mercaptoethanol, and transferred to a Qiagen
RNeasy Mini kit column. The extraction was completed
following the Qiagen protocol, which included an on-the-
column DNAse digest (Qiagen). Trace mammalian RNA
was removed from extracted RNA samples using the
MICROBEnrich™ Kit (Ambion). Samples were depleted of
rRNA using the MICROBExpress™ Bacterial mRNA En-
richment Kit. cDNA libraries were constructed using the
TruSeq RNA Sample Prep Kit (Illumina) and sequenced
using Illumina Hiseq 2000 (100 bp reads, single end) (six
samples/lane). Two separate replicates (one each for strains
FSL S3-586 and NEM316) grown in broth were excluded
from sequencing due to suspected cross contamination.
Summary sequencing statistics are shown in Table 1.
Differential gene expression, functional annotation,
and clustering
Adaptor sequences were removed from Illumina reads
using cutadapt [41]. Reads for each strain were then
mapped to respective genome sequences using BWA [42].
Genome sequences were obtained from GenBank (FSL
S3-586: ANCM01000000, CCUG 37738: ALQP01000000,
NEM316: NC_004368). Short read alignments were con-
verted to readable formats using SAMtools [43], and the
number of reads aligned to annotated genes was counted
using R [44]. Significant differences in expression be-
tween growth in milk and broth were determined using
DEseq [45]. The false discovery rate (FDR) procedure
of Benjamini and Hochberg [46] was used to correct for
multiple hypothesis testing (FDR = 0.05). Gene Ontology
(GO) terms were assigned to genes showing significantdifferential expression using Blast2GO v.2.5.0 [47]. These
genes were also assigned GO-Slim terms using the generic
GO Slim (http://www.geneontology.org/GO_slims/goslim_-
generic.obo). GO Slim is a reduced version of the full
GO that contains a sub-set of more general GO terms
and excludes the more fine-grained specific terms. This
approach provides a broad overview of the ontology
and gene product function for genomic data.
Genes for all three strains were delineated into hom-
ologous clusters using the MCL algorithm [48] as imple-
mented in the MCLBLASTLINE pipeline (available at
http://micans.org/mcl). The pipeline uses Markov clus-
tering (MCL) to assign genes to homologous clusters
based on a BLASTp search between all pairs of protein
sequences using an E value cut-off of 1e-5. The MCL al-
gorithm was implemented using an inflation parameter
of 1.8. Simulations have shown this value to be generally
robust to false positives and negatives [49].
Phylogenetic analysis
The lacGEFDCBA genes from the Lac.2 operon (see
Results and Discussion) for 60 Streptococcus strains (17
species) (Additional file 1) were aligned using MAFFT
v6.814b [50] as implemented in Geneious v5.5.3 [51]. A
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licates was constructed using PhyML v3.0 [52] and the
GTR + I + G substitution model, which was determined
as the best fit for the data using Modeltest v3.7 [53].
Results and discussion
Differential gene expression
The human isolate showed considerably more differen-
tial expression when grown in bovine milk than the
other two strains. Specifically, 305, 34, and 48 genes for
the human isolate, bovine isolate, and NEM316 showed
significantly more expression in bovine milk when com-
pared to broth (up regulation) (see Additional file 2).
This represents 14.4%, 1.4%, and 2.3% of the total num-
ber of genes in each genome respectively. The isolates
had similar numbers of genes with less expression in
milk relative to broth (down regulated): human = 298
(14.0%), bovine = 43 (1.8%), and NEM316 = 25 (1.2%).
The number of genes up regulated was not correlated
with growth. For example, in milk, final CFUs/μL were
highest for NEM316, followed by the bovine isolate,
and lastly the human isolate, with NEM316 showing
considerably more growth than the other two isolates
(Figure 1). In broth, the isolates showed less variation
in growth. Nevertheless, NEM316 again showed the
highest growth, with the other two strains showing ap-
proximately equal growth. Both NEM316 and the bo-
vine isolate showed higher growth in milk compared to
broth. However, the difference was far more pro-
nounced for NEM316. Conversely, the human isolate
showed more growth in broth than milk. Combined,CFU/µL
Hours
Figure 1 Growth curves, with standard error bars, for strains
FSL S3-586 (bovine sourced isolate), CCUG 37738 (human
sourced isolate), and NEM316 grown in bovine milk (solid line)
and THY broth (dashed line).these observations suggest that NEM316 and the bo-
vine isolate are better adapted to the bovine environ-
ment than the human isolate.
Figures 2 and 3 show the proportion of each of the
GO Slim terms that were assigned to the genes showing
differential expression. Proportions are relative to the
total number of terms assigned (genes can be assigned
multiple GO terms). Therefore, the chart shows the pro-
portional distribution of functional categories for the
genes differentially expressed for each isolate. The right
side of the chart shows proportions for terms assigned
to genes that were up regulated, whereas the left side
shows proportions for genes that were down regulated.
For each term, Fisher exact tests comparing the number
of up regulated genes to the number of down regulated
genes detected no significant differences for the bovine
isolate or NEM316 (FDR correction of 0.05). However,
tests for the human isolate detected 33 terms that were
significantly underrepresented for up regulated genes
and one term that was over represented (Figures 2 and
3). Of these terms, 16 were for biological processes, 15
were for cellular component, and three were for molecu-
lar function. For the biological processes terms, meta-
bolic and biosynthesis processes were the most frequent.
For example, there were eight terms associated with
metabolic processes and five terms associated with bio-
synthesis processes. The remaining three terms were for
translation, gene expression, and generation of precursor
metabolites and energy. These findings suggest a signifi-
cant reduction in metabolic activity for the human iso-
late when grown in bovine milk.
The human isolate was also distinctive regarding genes
involved in response to stress. Specifically, the following
four genes were up regulated: a CSD family cold shock
protein (SAG0061_02621), a universal stress family pro-
tein (SAG0061_03696), a heat shock protein GrpE
(SAG0061_10653), and a heat-inducible transcription re-
pressor (SAG0061_10658). The isolate showed a similar
stress response to growth in broth, with the following
three stress response genes showing up regulation: a uni-
versal stress family protein (SAG0061_03421), a heat
shock protein HtpX (SAG0061_03931), and a molecular
chaperone DnaK SAG0061_10648. In contrast, the bo-
vine isolate showed no up regulation for stress response
genes in either environment and NEM316 showed up
regulation for just one gene when grown in milk: a cold
shock protein (gbs2053). Concordant with the growth
patterns in milk, these results also suggest that the bo-
vine isolate and NEM316 are better adapted to the bo-
vine environment than the human isolate. However,
while these results also suggest that the bovine isolate
and NEM316 are better adapted to the broth environ-
ment than the human strain, this was not entirely
reflected by the growth patterns in broth as the bovine
---------------------------- unknown biological process -----------------------------
---------------------------------- metabolic process ------------------------------------
----------------------------- primary metabolic process ------------------------------
------------------------------------ cellular process -------------------------------------
 nucleobase, nucleoside, nucleotide and nucleic acid metabolic process
---------------- cellular nitrogen compound metabolic process -----------------
--------------------- nitrogen compound metabolic process ----------------------
----------------------------- cellular metabolic process ------------------------------
----------------------------------- catabolic process ------------------------------------
--------------------------------- biosynthetic process ----------------------------------
------------------------- carbohydrate metabolic process --------------------------
---------------------------- establishment of localization ----------------------------
---------------------------------------- localization ---------------------------------------
----------------------------------------- transport -----------------------------------------
---------------------------------- biological regulation ---------------------------------
--------------------------- regulation of biological process --------------------------
--------------------------------- response to stimulus ---------------------------------
------------------ cellular macromolecule metabolic process --------------------
------------------------ macromolecule metabolic process -------------------------
--------------------------- cellular response to stimulus -----------------------------
-------------------------- regulation of cellular process ------------------------------
----------------------------------------- signaling -----------------------------------------
---------------------------------- signal transduction -----------------------------------
---------------------------------------- cell cycle ------------------------------------------
--------------------------- regulation of biological quality ----------------------------
--------------------------------- homeostatic process ---------------------------------
---------------------------------- cellular homeostasis ---------------------------------
-------------------------- nucleic acid metabolic process ---------------------------
------------------------------ DNA metabolic process ---------------------------------
-------------------------------------- ion transport ---------------------------------------
------------------------------------------- death -------------------------------------------
---------------------------------------- cell death -----------------------------------------
------------------------------------ response to stress ---------------------------------
------------------------------------ gene expression ------------------------------------
---------------------------- cellular biosynthetic process ----------------------------
------------------ cellular macromolecule biosynthetic process -----------------
----------------------- macromolecule biosynthetic process -----------------------
---------------------------------------- translation ----------------------------------------
------------------------- cellular protein metabolic process ------------------------
---------------------------------protein metabolic process----------------------------
----------------------- establishment of protein localization -----------------------
----------------------------- macromolecule localization -----------------------------
------------------------------------ protein transport ------------------------------------
---------------------------------- protein localization -----------------------------------
--------------- generation of precursor metabolites and energy ----------------
-------------------------------- lipid metabolic process --------------------------------
---------------- cellular component organization or biogenesis -----------------
-------------------------- cellular component organization --------------------------
------------------------ anatomical structure development -------------------------
------------------------------- developmental process --------------------------------
----------------------- anatomical structure morphogenesis -----------------------
---------------- cellular component organization at cellular level ---------------
------ cellular component organization or biogenesis at cellular level ------
---------------------------- response to abiotic stimulus -----------------------------
-------------------------------- organelle organization --------------------------------
--------------- regulation of macromolecule metabolic process ----------------
------------------- regulation of gene expression, epigenetic --------------------
-------------------------- regulation of metabolic process --------------------------
--------------------------- regulation of gene expression ---------------------------
------------------------------- multi-organism process --------------------------------
------------------ interspecies interaction between organisms ------------------
---------- symbiosis, encompassing mutualism through parasitism ----------
---------------------------- macromolecule modification -----------------------------
---------------------------- protein modification process -----------------------------
--------------------------- response to external stimulus ----------------------------
---------------------------------- cell communication ----------------------------------
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Figure 2 Proportion of each of the GO Slim biological process terms assigned to genes showing differential expression. Green = FSL
S3-586 (bovine sourced isolate), red = NEM316, blue = CCUG 37738 (human sourced isolate). Right side of the chart shows proportions for terms
assigned to genes that showed significantly more expression in milk compared to broth (up regulated). Left side of the chart shows proportions
for terms assigned to genes that showed significantly more expression in broth compared to milk (down regulated in milk). An asterisk shows
terms for the human isolate that were significantly under represented for up regulated genes (FDR correction of 0.05).
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Figure 3 Proportion of each of the GO Slim molecular function and cellular component terms assigned to genes showing differential
expression. From the top of the chart, the first 28 terms are cellular component. Green = FSL S3-586 (bovine sourced isolate), red = NEM316,
blue = CCUG 37738 (human sourced isolate). Right side of the chart shows proportions for terms assigned to genes that showed significantly
more expression in milk compared to broth (up regulated). Left side of the chart shows proportions for terms assigned to genes that showed
significantly more expression in broth compared to milk (down regulated in milk). An asterisk shows terms for the human isolate that were significantly
underrepresented for up regulated genes when compared to down regulated genes. The # symbol shows a single term for the human isolate that was
significantly over represented for up regulated genes (FDR correction of 0.05). Note: the x-axis scale for down regulated genes ends at 0.2, whereas the
scale for the up regulated genes ends at 0.3.
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onment. In other words, despite the human isolate’s
strong stress response in broth, it was still able to grow
as well as the bovine isolate in this environment.
Interestingly, strain NEM316 does not appear as well-
adapted to human blood as it does to milk. For example,
Mereghetti et al. [29] reported that after 90 minutes growth
at 37°C and 40°C the following stress response genes were
up regulated: a universal stress family protein (gbs1721),
two general stress proteins (gbs1202 and gbs1204), a
chaperone (gbs0625), a ClpL protease (gbs1376gbs), and a
stress response regulator (gbs0756). Conversely, NEM316
might be as equally well adapted to human amniotic
fluid, as it appeared to be to milk, as Sitkiewicz et al.
[32] reported that it showed down regulation for all
stress response genes when grown in this environment
(with the exception of one gene [gbs2029–chaperonin
GroEL] that showed moderate up regulation).
Lactose operon
Both the bovine isolate and NEM316 showed up regula-
tion for a shared eight or nine gene operon that has been
shown to be involved in the transport and metabolism of
lactose [54] (Figure 4). The operon corresponds to what is
referred to as Lac.2 [55] and utilizes the phosphoenolpyr-
uvate (PEP)-dependant sugar-phosphotransferase system
(PTS). With one exception, the clustering analysis showed
all genes in the operon for each of the two isolates to be
homologous. The exception was NEM316, which pos-
sessed an additional gene: lacT. Another difference be-
tween the two operons was that lacR for the bovine
isolate was orientated in the opposite direction to the
remainder of the operon. Gene order for the operon
was as follows: lacRABCDFEGX (bovine isolate),Figure 4 Bar chart showing the relative proportion of the abundance
S3-586 when grown in milk and then broth. Read abundance is the me
shows abundance as follows: white bar = proportion of reads aligned for N
NEM316 when grown in broth, blue bar = proportion of reads aligned for F
for FSL S3-586 when grown in broth. LacT was absent in strain FSL S3-586lacRABCDTFEGX (NEM316). Both lacR and lacT may
have regulatory functions. For example, lacR is a puta-
tive negative regulator of the operon that likely func-
tions by binding to the promoter in the absence of
lactose [54,56,57], and in contrast to the remainder of
the operon, this gene was not up regulated. lacT is an
antiterminator, which may function to regulate down-
stream expression of lacFEGX. For Lactobacillis casei,
the lacT gene product is believed to bind to a ribo-
nucleic antiterminator (RAT) motif within an mRNA
secondary structure that prevents the formation of a
rho-independent terminator stem-loop structure that
would otherwise terminate downstream transcription
[58]. For NEM316, lacT was up regulated and a search
of the upstream 392 bp intergenic region using the
ARNold webserver (http://rna.igmors.u-psud.fr/tool-
box) detected a putative 65 bp rho-independent termin-
ator motif with a stem-loop free energy of -8.26 kcal/mol.
In addition, a putative -10 promoter consensus sequence
(TATAAT) was detected starting 98 bp upstream of the
start of the terminator. Although we could not detect a
motif resembling the proposed RAT consensus sequence
of Brown and Thompson [59], previously detected in
Streptococcus mutans [60], we did detect a 35 bp imper-
fect inverted repeat that was 100 bp upstream of the rho-
independent terminator that might function as a RAT.
While both the putatively bovine adapted isolates pos-
sessed Lac.2, the human isolate lacked it, and previous
examination of genome sequences for seven human
sourced isolates and one bovine sourced isolate also
showed that Lac.2 was only present in the bovine
sourced isolate [20]. Here we used BLASTn (E value
cut-off of 1e-5) to survey an additional 202 S. agalactiae
genome sequences available on GenBank (see Additionalof reads aligned to each Lac.2 gene for strains NEM316 and FSL
an of the normalized count of reads for each set of replicates. Chart
EM316 when grown in milk, black bar = proportion of reads aligned for
SL S3-586 when grown in milk, red bar = proportion of reads aligned
(see Results and Discussion).
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lated from a range of vertebrate hosts: human = 151, bo-
vine = 35, tilapia = 13, dolphin = 1, bullfrog = 1, and grey
seal = 1. Lac.2 was present in 42 isolates. This included
all 35 bovine sourced isolates and seven human sourced
isolates. Again using BLASTn, we determined the MLST
ST for each isolate (including the bovine and human iso-
lates analyzed using RNAseq data). All of these genome
sequences were WGS, and as a consequence, MLST al-
leles were occasionally truncated. Therefore, we were
unable to determine allele profiles for 21 isolates. Of the
seven human sourced isolates that possessed Lac.2, three
were ST-88, two were undetermined, and the remaining
two were ST-25 and ST-103. ST-88 and ST-25 belong to
clonal complex 23, which also includes ST-23 (NEM316).
These results clearly show a very strong correlation be-
tween Lac.2 and the bovine environment (all bovine
sourced isolates possessed the operon).
We identified 17 different STs for the bovine isolates
(Additional file 1) and previous studies have shown these
STs to not cluster together in phylogentic analyses
[35,61]. Furthermore, there were numerous examples
where the possession of Lac.2 was not conserved for all
isolates of the same ST. For example, ST-1 occurred 19
times, yet only three of the isolates with this ST pos-
sessed Lac.2 (Additional file 1). Other examples were
ST-23 (n = 16, Lac.2 = 1), ST-7 (n = 9, Lac.2 = 1), ST-88
(n = 6, Lac.2 = 3), and ST-2 (n = 5, Lac.2 = 1). Combined,
these findings strongly suggest that acquisition of Lac.2
was via lateral gene transfer (LGT) rather than vertical
inheritance. LGT of this operon is further supported by
previous work showing that Lac.2 was likely exchanged
between a bovine sourced isolate of S. agalactiae and an-
other mastitis causing pathogen Streptococcus dysgalac-
tiae subsp. dysgalactiae via an integrative conjugative
element (ICE) [20]. Furthermore, Lac.2 is also within an
ICE for NEM316 and another species of Streptococcus
(Streptococcus canis - FSL S3-227) [62]. Strain FSL S3-
227 was isolated from a cow with an intra-mammary in-
fection that belonged to a dairy herd experiencing an
outbreak of S. canis induced mastitis [63].
Evolution of Lac.2
We further explored the evolutionary history of Lac.2 by
aligning the operon from each S. agalactiae isolate to 16
additional Streptococcus species representing a range of
phylogenetic groups (mitis, sanguinis, mutans, pyogenic,
and bovis) and then constructed a maximum likelihood
phylogeny (see Methods, Figure 5, and Additional file 1).
The genes lacX, lacT, and lacR were not consistently
present in all isolates nor species and were therefore ex-
cluded from the analysis. Within the phylogeny, the
Lac.2 sequences for S. agalactiae formed four major
groupings (A, B, C, and D) that were strongly supported.Three (B, C, and D) clustered together, while the fourth
(A), which contained NEM316, was very distantly related
(10 of the additional Streptococcus species separated
them). As described above, S. agalactiae isolates pos-
sessed one of two different types of Lac.2 operon. Here
we designate them Lac.2-1 (lacT present and lacR orien-
tated in the same direction as the remainder of the op-
eron) and Lac.2-2 (lacT missing and lacR orientated in
the opposite direction). Four isolates within group D
lacked lacR (Additional file 1 and Figure 5). When the
two types of Lac.2 were overlain on the phylogeny, they
clustered separately, with groups A, B, and C exclusively
containing Lac.2-1 and group D exclusively containing
Lac.2-2, suggesting distinct evolutionary histories for the
Lac.2 types. Four of the additional Streptococcus species
fell within group D (S. dysgalactiae subsp. dysgalactiae,
Streptococcus pyogenes, Streptococcus parauberis, and
Streptococcus urinalis) and two within group C (Strepto-
coccus dysgalactiae subsp. equisimilis and Streptococcus
uberis). The close relationship between these additional
species and the S. agalactiae group they fell within, com-
pared to the much larger evolutionary distance among
the S. agalactiae groups lends further support for the
lateral exchange of Lac.2 between S. agalactiae and
other Streptococcus species. It’s noteworthy that S. dysga-
lactiae subsp. dysgalactiae, S. uberis, and S. parauberis
are major causes of mastitis and were all isolated from
the bovine environment, suggesting this exchange may
have occurred within this environment. However, three
additional Streptococcus species, all isolated from the hu-
man environment, also fell within groups C (S. dysgalac-
tiae subsp. equisimilis) and D (S. pyogenes and S.
urinalis), raising the possibility that exchange may have
also occurred in the human environment. One S. agalac-
tiae strain (LMG 14838) was particularly interesting, as
it possessed both types of Lac.2, with the phylogeny
showing them to be highly divergent, likely reflecting ac-
quisition of the operon on separate occasions from dif-
ferent species. None of the additional species included
in the phylogeny fell within groups A and B. Therefore,
in an attempt to identify possible donor species, we per-
formed a BLASTn search of the nr database at NCBI
using a representative sequence from each group. The
best hit for each group was Streptococcus sanguinis
(group A) and S. dysgalactiae subsp. equisimilis (group
B). Unfortunately, these two species were already in-
cluded in our phylogeny and were the closest species to
each group. Consequently, the likely donor species for
these two groups remains unknown.
The role of Lac.1
The previous examination of genome sequences for
seven human and one bovine sourced isolate showed
that in addition to Lac.2, all S. agalactiae isolates possessed
Figure 5 Maximum likelihood phylogeny showing relationship among lacGEFDCBA genes from the Lac.2 operon for 44 S. agalactiae
strains and 16 additional Streptococcus species. S. agalactiae strains are labeled using their 4-letter accession prefix. See Additional file 1 for
cross reference to all strain names. Four major S. agalactiae groups are shaded.
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aminidase-ABCDX [20]. The clustering analysis per-
formed here showed that although genes ABCDX were
homologous with those in Lac.2, the operon lacked
lacG, a cytoplasmic phospho-β-galactosidase that hy-
drolyzes the lactose-6-phosphate produced when lactose
is transported into the cell via the PTS. The lactose-6-
phosphate is hydrolyzed to galactose-6-phosphate prior
to it passing through the tagatose-6-phosphate pathway.
Consequently, the absence of lacG in Lac.1 suggests that
the operon’s primary function is not the metabolism of
lactose, and Loughman and Caparon [56] suggested a
virulent role for the operon in S. pyogenes. Similarly,
Lac.1 in S. agalactiae contains neuraminidase, which
has been implicated in virulence, also suggesting an al-
ternative role for the operon [64,65]. However, a
BLASTn search for lacG in the 202 genome sequences
showed it to be present somewhere within the genomeof all isolates, raising the possibility that the Lac.1
operon, in concert with lacG, might still play a role in
lactose metabolism. However, while the differential ex-
pression analysis showed Lac.1 to be up regulated in
milk for the human isolate and NEM316 (Additional file
2), lacG was not upregulated. For the bovine isolate, Lac.1
showed no differential expression, which was likely due to
the fact that the operon had been split into two fragments,
probably due to insertion sequences that flanked one of
the fragments. Similarly, Lac.1 in bovine isolate FSL S3-
026 was also fragmented by insertion sequences [20]. Using
BLASTn we surveyed the 202 genome sequences for the
presence of Lac.1. For all isolates, we found the operon to
be either contiguous, or its genes to be distributed on
two or more contigs. It was contiguous in 150 isolates
(human = 120, bovine = 18, tilapia = 9, bullfrog = 1, grey
seal = 1, dolphin = 1), and distributed on two or more con-
tigs in 51 isolates (human = 31, bovine = 16, tilapia = 4).
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To further investigate the ability of different S. agalac-
tiae isolates to metabolize lactose and the roles of Lac.1
and Lac.2, we performed a lactose fermentation test on a
set of 124 isolates (Additional file 1). These isolates rep-
resented a subset of the 202 isolates whose genome se-
quences we analyzed earlier, plus the isolates analyzed
here using RNAseq data and the bovine isolate FSL S3-
026 (human = 74, bovine = 36, tilapia = 11, bullfrog = 1,
grey seal = 1, dolphin = 1). All isolates possessing Lac.2
showed a positive result for lactose fermentation (media
changed to yellow), lending further support to the role
of Lac.2 in lactose metabolism. With the exception of
three isolates that showed no color change, the media
for all remaining isolates changed to orange, suggesting
some minimal acid production and fermentation activity.
Although showing positive for lactose fermentation, the
genome sequence of strain FSL S3-442 lacked Lac.2. We
designed a PCR test to investigate whether this was due
to a sequencing omission (i.e. this particular region of
the genome had not been sequenced). Primers designed
within lacF and lacG amplified a ~2.5 kbp region specific
to Lac.2 (lacFEG) confirming the operon’s presence. Al-
though it’s possible that a similar sequencing omission
could have occurred in another strain, an omission of
this size is likely a rare occurrence.
Overall, our results suggest that the ability to me-
tabolize lactose at a significant level, was acquired via
the lateral transfer of the Lac.2 operon and that this was
likely an important adaptation to the bovine environ-
ment. Furthermore, this mechanism permits rapid adap-
tation and may explain why some STs suddenly become
more prevalent within the bovine environment. For ex-
ample, the recent rapid increase in the prevalence of ST-
1, ST-23, and ST-103 in Danish dairy herds [5]. These
findings also serve to highlight how attempts to correlate
adaptive traits with STs may be misleading (e.g. not all
isolates of the same ST possess Lac.2).
Assuming that S. agalactiae acquired Lac.2 within the
bovine environment, the isolation of strains from the hu-
man environment possessing Lac.2 highlights the poten-
tial for the bovine environment to serve as a reservoir
for the emergence of more virulent strains with subse-
quent transmission to the human population. Further-
more, if LGT is the dominant adaptive process, as also
proposed by Sørenson et al. [35], a dependence on
MLST as the primary source of molecular epidemio-
logical data will likely prove inadequate for accurate elu-
cidation of these processes. For example, the proposal
that the hyperinvasive neonatal ST-17 evolved via verti-
cal inheritance from a bovine ancestor [15] was based
on a phylogenetic analysis of ST data. However, more
detailed genomic examination has called the accuracy of
this relationship into question [12,35], and our resultsadditionally provide no support for this relationship.
Specifically, fifteen of the genome sequences surveyed
here were ST-17 and none of these isolates possessed
Lac.2. Therefore, our results provide no support for ST-
17 being derived from a bovine adapted strain.
Additional patterns of differential expression
There were nine genes uniquely up regulated in the bo-
vine isolate (Table 2 and Additional file 3). Two were
hypothetical proteins and in general the remainder had
roles in binding and membrane transport. One of the
genes involved in membrane transport was a copper-
transporter ATPase CopA. While essential for life, cop-
per is also highly toxic to cells in excess. The CopA gene
product is a copper efflux ATPase involved in copper
homeostasis [66,67], and disruption of the gene in
Escherichia coli has been shown to produce sensitivity to
copper [68]. Copper is present as a trace element in bo-
vine milk [69,70] and up regulation of CopA may con-
tribute to extended survival for the bovine isolate within
the udder.
In addition to the Lac.2 genes, there were five up regu-
lated genes shared between the bovine isolate and
NEM316 that were not up regulated for the human iso-
late (Table 2 and Additional file 3). These genes were all
involved in metabolic processes, with four of them spe-
cifically involved in the metabolism of purine (purC,
purF, guaC) and pyrimidine (pyrD). The purine and pyr-
imidine biosynthetic pathways have been shown to be
critical for growth in human blood for other gram posi-
tive and negative bacteria [71], and our results show they
may also be important for growth in bovine milk. How-
ever, Mereghetti et al. [30] found considerably greater
expression for these pathways in NEM316 when grown
in human blood. Specifically, ten of the 17 genes in the
purine pathway and five of the six genes in the pyrimi-
dine pathway were up regulated, suggesting a more im-
portant role during growth in blood than milk. In
addition, these observations describe a distinctive meta-
bolic contrast for NEM316 when grown in bovine milk
compared to human blood. In milk, all of the genes in
the Lac.2 operon were up regulated, whereas only four
genes in the purine and pyrimidine biosynthetic path-
ways were up regulated. In contrast, growth in blood re-
sulted in up regulation of all the genes in the purine and
pyrimidine pathways and just two in Lac.2 (lacD and
lacE) [30]. These observations reveal a metabolic flexibil-
ity for NEM316, where the strain can up or down regu-
late different metabolic pathways to various levels of
expression depending on the environment.
The fifth of the up regulated genes shared between
the bovine isolate and NEM316 was a GCN5-related N-
acetyltransferase (GNAT). An important activity of
some members of this family of genes is antibiotic
Table 2 Uniquely up regulated genes for S. agalactiae strains NEM316 and FSL S3-586
Strain Locus tag Gene Sequence description
FSL S3-586A FSLS3586_00500 Family transcriptional regulator
FSL S3-586A FSLS3586_01665 Xanthine uracil permease family protein
FSL S3-586A FSLS3586_04875 23S rRNA (uracil-5-)-methyltransferase
FSL S3-586A FSLS3586_07316 Conjugal transfer protein
FSL S3-586A FSLS3586_07998 Cyclic nucleotide-binding domain protein
FSL S3-586A FSLS3586_08765 XerS Site-specific tyrosine recombinase
FSL S3-586A FSLS3586_09285 Hypothetical protein
FSL S3-586A FSLS3586_09582 Hypothetical protein
FSL S3-586A FSLS3586_10962 CopA Copper-translocating P-type ATPase
FSL S3-586B FSLS3586_02692 lacG 6-phospho-beta-galactosidase
NEM316B gbs1329 lacG 6-phospho-beta-galactosidase
FSL S3-586B FSLS3586_05359 pyrD Dihydroorotate dehydrogenase 1A
NEM316B gbs0553 pyrD Dihydroorotate dehydrogenase 1A
FSL S3-586B FSLS3586_10188 guaC Guanosine 5-monophosphate oxidoreductase
NEM316B gbs1154 guaC Guanosine 5-monophosphate oxidoreductase
FSL S3-586B FSLS3586_09702 purF Amidophosphoribosyltransferase
NEM316B gbs0025 purF Amidophosphoribosyltransferase
FSL S3-586B FSLS3586_09687 GNAT family acetyltransferase
NEM316B gbs0028 GNAT family acetyltransferase
FSL S3-586B FSLS3586_09712 purC Phosphoribosylaminoimidazole-succinocarboxamide synthase
NEM316B gbs0023 purC Phosphoribosylaminoimidazole-succinocarboxamide synthase
FSL S3-586B FSLS3586_02702 lacF PTS lactose-specific IIA component
NEM316B gbs1331 lacF Lactose-specific phosphotransferase enzyme IIA component
FSL S3-586B FSLS3586_02697 lacE PTS lactose-specific iibc component
NEM316B gbs1330 lacE PTS family lactose porter iicb component
NEM316C gbs0668 D-lactate dehydrogenase
NEM316C gbs0789 Major facilitator superfamily protein
NEM316C gbs1264 Alpha-acetolactate decarboxylase
NEM316C gbs1332 lacT Transcription antiterminator
NEM316C gbs1508 4-alpha-glucanotransferase
NEM316C gbs1619 D-3-phosphoglycerate dehydrogenase
NEM316C gbs1627 CBS domain protein
NEM316C gbs1630 Branched-chain amino acid ABC superfamily ATP binding cassette permease protein
NEM316C gbs1631 Branched-chain amino acid ABC superfamily ATP binding cassette membrane protein
NEM316C gbs1632 Branched-chain amino acid ABC amino acid-binding protein
NEM316C gbs2002 Glycerol dehydrogenase
Superscript A = genes uniquely up regulated for FSL S3-586, superscript B = genes uniquely up regulated for FSL S3-586 and NEM316, superscript C = genes
uniquely up regulated for NEM316.
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gene’s role in S. agalactiae further, we performed a
BLASTn search of the nr database at NCBI using the
NEM316 nucleotide sequence. The top five hits were
for S. agalactiae strains, with each hit having a similar
gene annotation to NEM316. However, the next best
hit was for a Zwittermicin A resistance protein zmaRfrom Lactobacillus salivarius (72% identity, 44% cover-
age), lending support to the possibility that the S. aga-
lactiae GNAT gene may also be involved in antibiotic
resistance. S. agalactiae infection is frequently treated
with antibiotics [9]. Furthermore, blanket dry cow ther-
apy (infusion of the udder with antibiotics during the
dry period as a mastitis preventative measure) is now
Richards et al. BMC Genomics 2013, 14:920 Page 12 of 15
http://www.biomedcentral.com/1471-2164/14/920common place within the US dairy industry [74]. A com-
monly used antibiotic is penicillin-dihydrostreptomycin
(Quartermaster; Pfizer Animal Health) [74] and dihy-
drostreptomycin is an aminoglycoside antibiotic. Conse-
quently, up regulation of the putative antibiotic resistance
gene might reflect an adaptation to this type of treatment
where growth in milk elicits high expression of the gene
for bovine adapted strains. Indeed, Brown and Scasserra
[75] reported low susceptibility to streptomycin for S.
agalactiae isolated from bovine mammary glands. An
alternative explanation for up regulation of the gene is
the presence of an antibiotic in the milk sample. This
seems unlikely as none of the four cows providing the
milk were treated with antibiotics for six months prior
to milk collection. Regardless, the potential role of this
gene in antibiotic resistance remains preliminary with-
out further functional analyses.
For NEM316, there were 11 uniquely up regulated
genes (Table 2 and Additional file 3). In general, these
genes had roles in oxidation-reduction processes and
membrane transport. One of these genes was a glycerol
dehydrogenase. These enzymes are utilized in the me-
tabolism of glycerol, which bacteria can use as a carbon
source in anaerobic conditions through coupled oxida-
tive and reductive pathways [76-78]. The triglycerides in
bovine milk contain glycerol and the up regulation of
glycerol dehydrogenase for NEM316 suggests that the
isolate might be utilizing glycerol as a carbon source.
Furthermore, glycerol-catabolizing enzymes have been
shown to be important for bacterial growth [79] and
NEM316 showed considerably more growth in milk than
the other two isolates (Figure 1). An additional up regu-
lated dehydrogenase was D-lactate dehydrogenase. Lac-
tose is composed of β-D-galactose and α/β-D-glucose.
After transport of lactose into the cell via the PTS, lacG
hydrolyzes lactose-6-phosphate into both galactose-6-
phosphate and glucose [80] (galactose-6-phosphate is
passed to the tagatose pathway [Lac.2] as discussed
above). The final product of the glycolysis of glucose is
pyruvate, and when oxygen is absent or in short supply,
D-lactate dehydrogenase converts pyruvate to lactate
[81]. Consequently, up regulation of D-lactate dehydro-
genase suggests active metabolism of the glucose com-
ponent of lactose for NEM316. Glucose metabolism is
also indicated by the up regulation of α-acetolactate de-
carboxylase, which is involved in the anabolism of acet-
oin from pyruvate [82]. This gene activity might again
contribute to strain NEM316’s stronger growth in milk.
Nisin and insertion sequences
Streptococcus uberis possesses an 11-gene operon for the
production of the lantibiotic nisin [83]. The operon is
part of the species' dispensable genome, [83] and Pryor
et al. [84] showed that nisin producer strains dominatednon-producer strains during intramammary infection,
suggesting a competitive advantage. S. agalactiae (stain
FSL S3-026) also possesses the operon [20]. However,
the operon is disrupted by an insertion sequence (IS)
and a deferred antagonism test showed the strain to not
produce nisin. The bovine S. agalactiae isolate studied
here (strain FSL S3-586) also possessed the operon; but
again the operon was disrupted by insertion sequences
(fragmented into two). However, all 11 operon genes
showed some expression in milk, whereas only five
showed expression in broth. However, this expression
was not significantly different between the two environ-
ments and a previous deferred antagonism test showed
the strain to not produce nisin [20]. Similar to strain
FSL S3-026, strain FSL S3-586 also possessed numerous
insertion sequences (122) throughout its genome, lend-
ing further support to the importance of IS activity in
the evolution of S. agalactiae. A total of 106 (86.9%) of
the 122 IS showed no gene expression in either milk or
broth, while 12 IS were expressed in both environments,
although not differentially, suggesting some IS activity in
both environments. Four IS showed negligible expres-
sion in milk only. The human isolate contained consid-
erably fewer IS (42). However, there was a similar
number of IS showing expression in both environments
(11). The lower number of IS for human isolates may be
typical, as the average number of IS for the human S.
agalactiae isolates 2603 V/R, H36B, 18RS21, A909, 515,
CJB111, and COH1 was 23 [20]. NEM316 is somewhat
distinctive in that it possesses a comparatively very low
number of IS (5), with three showing expression in both
environments. The high number of IS for the bovine iso-
lates might reflect a degree of specialization to this en-
vironment. For example, several studies have suggested
that proliferation of insertion sequences is an evolution-
ary signature that accompanies the transition to a more
specialized life style [85-88]. Specifically, in any popula-
tion, the transposition of IS into genes occurs at a par-
ticular rate, and in large populations, if a transposition is
lethal or results in a selective disadvantage, the bacterial
will be removed from the population via purifying selec-
tion. However, the reduction in population size that typ-
ically accompanies specialization increases the effect of
genetic drift, which is now able to fix more of the dele-
terious transpositions into the population. The very low
number of IS for NEM316 might reflect a larger popula-
tion size associated with a more generalist ability (ST-23
has the widest reported host distribution).
Conclusion
Our study detected numerous genetic factors likely im-
portant in S. agalactiae’s adaptation to the bovine envir-
onment. In particular, the acquisition of Lac.2 and the
ability to efficiently metabolize lactose appears to have
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dence supporting LGT as the mechanism responsible for
this adaptation, and rather than being a single evolution-
ary event, it appears to have occurred multiple times,
with all Streptococcus species known to be major causes
of mastitis identified as possible donors. This process
has resulted in genetically divergent types of Lac.2
within S. agalatiae warranting further investigation into
the possible affects this has on survivability and the pro-
pensity to cause mastitis. Other factors such as up regu-
lation of genes involved in copper homeostasis, and
metabolism of purine, pyrimidine, glycerol and glucose
were also specific to bovine adapted strains. Although
somewhat speculative without further functional studies,
the up regulation of a GNAT gene during growth in milk
that may impart antibiotic resistance, was of particular
interest, as it hinted at an adaptation to the use of anti-
biotics within this environment. Other mastitis causing
pathogens are less responsive to antibiotics [10] and the
evidence provided here and elsewhere, for LGT between
S. agalactiae and these species, highlights the potential for
further development and spread of antibiotic resistance.
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